SARS-CoV-2 cell entry and targeted antiviral development

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the pandemic coronavirus disease 2019 (COVID-19), which threatens human health and public safety. In the urgent campaign to develop anti-SARS-CoV-2 therapies, the initial entry step is one of the most appealing ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zinuo, Du, Ruikun, Galvan Achi, Jazmin M., Rong, Lijun, Cui, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117542/
https://www.ncbi.nlm.nih.gov/pubmed/34002130
http://dx.doi.org/10.1016/j.apsb.2021.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117542/
https://www.ncbi.nlm.nih.gov/pubmed/34002130
http://dx.doi.org/10.1016/j.apsb.2021.05.007

Ejemplares similares